{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:03:20Z","timestamp":1791921800618,"version":"4.3.4"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key R&D Program of Hunan Province","award":["2024JK2108"],"award-info":[{"award-number":["2024JK2108"]}]},{"name":"Wu Jieping Medical Foundation Research Special Fund","award":["320.6750.2023-19-30"],"award-info":[{"award-number":["320.6750.2023-19-30"]}]},{"name":"Hunan Provincial NSF Key Project","award":["2025JJ30008"],"award-info":[{"award-number":["2025JJ30008"]}]},{"name":"Hunan Furong Program High-Level Health Talent Support Project","award":["20241226039"],"award-info":[{"award-number":["20241226039"]}]},{"name":"High-Level Talent Support Program of Hunan Cancer Hospital","award":["202507311010"],"award-info":[{"award-number":["202507311010"]}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2023JJ30887"],"award-info":[{"award-number":["2023JJ30887"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02649-y","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T14:46:29Z","timestamp":1775054789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["YAP1 in control: how RNA networks and protein modifications shape its function and therapeutic targetability"],"prefix":"10.1186","volume":"25","author":[{"given":"Jin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erya","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"2649_CR1","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","volume":"17","author":"FD Camargo","year":"2007","unstructured":"Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol. 2007;17:2054\u201360.","journal-title":"Curr Biol"},{"key":"2649_CR2","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-2247","volume":"9","author":"Y Li","year":"2021","unstructured":"Li Y, Wang W, Wu X, Ling S, Ma Y, Huang P. SLC7A5 serves as a prognostic factor of breast cancer and promotes cell proliferation through activating AKT\/mTORC1 signaling pathway. Ann Transl Med. 2021;9:892.","journal-title":"Ann Transl Med"},{"key":"2649_CR3","doi-asserted-by":"crossref","unstructured":"Pandya M, Gopinathan G, Tillberg C, Wang J, Luan X, Diekwisch TGH. The hippo pathway effectors YAP\/TAZ are essential for mineralized tissue homeostasis in the alveolar bone\/periodontal complex. J Dev Biol. 2022;10:14.","DOI":"10.3390\/jdb10010014"},{"key":"2649_CR4","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.7150\/ijbs.47142","volume":"16","author":"X Chen","year":"2020","unstructured":"Chen X, Yuan W, Li Y, Luo J, Hou N. Role of hippo-YAP1\/TAZ pathway and its crosstalk in cardiac biology. Int J Biol Sci. 2020;16:2454\u201363.","journal-title":"Int J Biol Sci"},{"key":"2649_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","volume":"19","author":"D Pan","year":"2010","unstructured":"Pan D. The hippo signaling pathway in development and cancer. Dev Cell. 2010;19:491\u2013505.","journal-title":"Dev Cell"},{"key":"2649_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89855-4","volume":"11","author":"X Yang","year":"2021","unstructured":"Yang X, Nanayakkara J, Claypool D, Saghafinia S, Wong JJM, Xu M, et al. A miR-375\/YAP axis regulates neuroendocrine differentiation and tumorigenesis in lung carcinoid cells. Sci Rep. 2021;11:10455.","journal-title":"Sci Rep"},{"key":"2649_CR7","doi-asserted-by":"crossref","unstructured":"Zhong D, Xu GZ, Wu JZ, Liu H, Tang JY, Wang CG. Circ-ITCH sponges miR-214 to promote the osteogenic differentiation in osteoporosis via upregulating YAP1. Cell Death Dis. 2021;12:340.","DOI":"10.1038\/s41419-021-03586-y"},{"key":"2649_CR8","doi-asserted-by":"crossref","unstructured":"Yang Q, Wang M, Xu J, Yu D, Li Y, Chen Y, Zhang X, Zhang J, Gu J, Zhang X. LINC02159 promotes non-small cell lung cancer progression via ALYREF\/YAP1 signaling. Mol Cancer. 2023;22:122.","DOI":"10.1186\/s12943-023-01814-x"},{"key":"2649_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8875424","volume":"2021","author":"W Zhou","year":"2021","unstructured":"Zhou W, Xian Q, Wang Q, Wu C, Yan H, Li X, et al. m6A methyltransferase 3 promotes the proliferation and migration of gastric cancer cells through the m6A modification of YAP1. J Oncol. 2021;2021:8875424.","journal-title":"J Oncol"},{"key":"2649_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.00018-22","volume":"42","author":"SZ Brown","year":"2022","unstructured":"Brown SZ, McCarthy GA, Carroll JR, Di Niro R, Pelz C, Jain A, et al. The RNA-binding protein HuR posttranscriptionally regulates the protumorigenic activator YAP1 in pancreatic ductal adenocarcinoma. Mol Cell Biol. 2022;42:e0001822.","journal-title":"Mol Cell Biol"},{"key":"2649_CR11","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1038\/s41589-023-01391-6","volume":"19","author":"L Sun","year":"2023","unstructured":"Sun L, Suo C, Zhang T, Shen S, Gu X, Qiu S, et al. ENO1 promotes liver carcinogenesis through YAP1-dependent arachidonic acid metabolism. Nat Chem Biol. 2023;19:1492\u2013503.","journal-title":"Nat Chem Biol"},{"key":"2649_CR12","doi-asserted-by":"publisher","first-page":"14452","DOI":"10.1002\/cam4.6074","volume":"12","author":"J Deng","year":"2023","unstructured":"Deng J, Yi X, Feng Z, Peng J, Li D, Li C, et al. Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial-mesenchymal transition by stabilizing YAP1. Cancer Med. 2023;12:14452\u201367.","journal-title":"Cancer Med"},{"key":"2649_CR13","doi-asserted-by":"crossref","unstructured":"Wang X, Zou C, Hou C, Bian Z, Jiang W, Li M, Zhu L. Extracellular vesicles from bone marrow mesenchymal stem cells alleviate osteoporosis in mice through USP7-mediated YAP1 protein stability and the Wnt\/\u03b2-catenin pathway. Biochem Pharmacol. 2023;217:115829.","DOI":"10.1016\/j.bcp.2023.115829"},{"key":"2649_CR14","first-page":"2145","volume":"9","author":"M Sudol","year":"1994","unstructured":"Sudol M. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene. 1994;9:2145\u201352.","journal-title":"Oncogene"},{"key":"2649_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ydbio.2020.12.018","volume":"475","author":"F Szulzewsky","year":"2021","unstructured":"Szulzewsky F, Holland EC, Vasioukhin V. YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance. Dev Biol. 2021;475:205\u201321.","journal-title":"Dev Biol"},{"key":"2649_CR16","doi-asserted-by":"publisher","first-page":"13965","DOI":"10.1074\/jbc.RA120.013820","volume":"295","author":"C Ben","year":"2020","unstructured":"Ben C, Wu X, Takahashi-Kanemitsu A, Knight CT, Hayashi T, Hatakeyama M. Alternative splicing reverses the cell-intrinsic and cell-extrinsic pro-oncogenic potentials of YAP1. J Biol Chem. 2020;295:13965\u201380.","journal-title":"J Biol Chem"},{"key":"2649_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1097-2765(02)00776-1","volume":"11","author":"S Basu","year":"2003","unstructured":"Basu S, Totty NF, Irwin MS, Sudol M, Downward J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell. 2003;11:11\u201323.","journal-title":"Mol Cell"},{"key":"2649_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","volume":"122","author":"J Huang","year":"2005","unstructured":"Huang J, Wu S, Barrera J, Matthews K, Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell. 2005;122:421\u201334.","journal-title":"Cell"},{"key":"2649_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/cbf.3119","volume":"33","author":"CJ Lei","year":"2015","unstructured":"Lei CJ, Li L, Gao X, Zhang J, Pan QY, Long HC, et al. Hsa-miR-132 inhibits proliferation of hepatic carcinoma cells by targeting YAP. Cell Biochem Funct. 2015;33:326\u201333.","journal-title":"Cell Biochem Funct"},{"key":"2649_CR20","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1136\/gutjnl-2022-327492","volume":"72","author":"J Liu","year":"2023","unstructured":"Liu J, Bai W, Zhou T, Xie Y, Yang B, Sun J, et al. SDCBP promotes pancreatic cancer progression by preventing YAP1 from \u03b2-TrCP-mediated proteasomal degradation. Gut. 2023;72:1722\u201337.","journal-title":"Gut"},{"key":"2649_CR21","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1158\/0008-5472.CAN-21-1628","volume":"82","author":"Y Chen","year":"2022","unstructured":"Chen Y, Ling Z, Cai X, Xu Y, Lv Z, Man D, et al. Activation of YAP1 by N6-methyladenosine\u2013modified circCPSF6 drives malignancy in hepatocellular carcinoma. Cancer Res. 2022;82:599\u2013614.","journal-title":"Cancer Res"},{"key":"2649_CR22","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.7150\/ijbs.66224","volume":"18","author":"J Li","year":"2022","unstructured":"Li J, Jiang X, Xu Y, Kang P, Huang P, Meng N, et al. YY1-induced DLEU1\/miR-149-5p promotes malignant biological behavior of cholangiocarcinoma through upregulating YAP1\/TEAD2\/SOX2. Int J Biol Sci. 2022;18:4301\u201315.","journal-title":"Int J Biol Sci"},{"key":"2649_CR23","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/liv.15240","volume":"42","author":"H Zheng","year":"2022","unstructured":"Zheng H, Zhu M, Li W, Zhou Z, Wan X. M(5) c and m(6) a modification of long noncoding NKILA accelerates cholangiocarcinoma progression via the miR-582-3p-YAP1 axis. Liver Int. 2022;42:1144\u201357.","journal-title":"Liver Int"},{"key":"2649_CR24","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1158\/1078-0432.CCR-19-0674","volume":"26","author":"N Li","year":"2020","unstructured":"Li N, Yang G, Luo L, Ling L, Wang X, Shi L, et al. LncRNA THAP9-AS1 promotes pancreatic ductal adenocarcinoma growth and leads to a poor clinical outcome via sponging miR-484 and interacting with YAP. Clin Cancer Res. 2020;26:1736\u201348.","journal-title":"Clin Cancer Res"},{"key":"2649_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04500-w","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, Tian Y, He J, Tian Y, Zhang G, Zhao R, et al. Linc01133 contributes to gastric cancer growth by enhancing YES1-dependent YAP1 nuclear translocation via sponging miR-145-5p. Cell Death Dis. 2022;13:51.","journal-title":"Cell Death Dis"},{"key":"2649_CR26","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1038\/s41388-020-1213-8","volume":"39","author":"K Liu","year":"2020","unstructured":"Liu K, Wang BJ, Han W, Chi CH, Gu C, Wang Y, et al. CFIm25-regulated lncRNA acv3UTR promotes gastric tumorigenesis via miR-590-5p\/YAP1 axis. Oncogene. 2020;39:3075\u201388.","journal-title":"Oncogene"},{"key":"2649_CR27","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1161\/CIRCULATIONAHA.121.056850","volume":"145","author":"H Li","year":"2022","unstructured":"Li H, Trager LE, Liu X, Hastings MH, Xiao C, Guerra J, et al. LncExACT1 and DCHS2 regulate physiological and pathological cardiac growth. Circulation. 2022;145:1218\u201333.","journal-title":"Circulation"},{"key":"2649_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04105-9","volume":"12","author":"X Deng","year":"2021","unstructured":"Deng X, Ye D, Hua K, Song H, Luo Q, Munankarmy A, et al. MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor. Cell Death Dis. 2021;12:810.","journal-title":"Cell Death Dis"},{"key":"2649_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-025-10033-7","volume":"41","author":"Y Xie","year":"2025","unstructured":"Xie Y, Chen X, Liang T, Chen L, Liu D. Mitigating chemotherapy-induced granulosa cell damage: role of hUCMSC-EVs in regulating the lncRNA HCP5-miR-20a-5p-YAP1 network. Cell Biol Toxicol. 2025;41:79.","journal-title":"Cell Biol Toxicol"},{"key":"2649_CR30","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.2147\/JIR.S491724","volume":"18","author":"R Li","year":"2025","unstructured":"Li R, Huang Z, Chen M. Long non-coding RNA EPB41L4A-AS1 serves as a diagnostic marker for chronic periodontitis and regulates periodontal ligament injury and osteogenic differentiation by targeting miR-214-3p\/YAP1. J Inflamm Res. 2025;18:2483\u201397.","journal-title":"J Inflamm Res"},{"key":"2649_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jhep.2021.08.027","volume":"76","author":"Q Chen","year":"2022","unstructured":"Chen Q, Wang H, Li Z, Li F, Liang L, Zou Y, et al. Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription. J Hepatol. 2022;76:135\u201347.","journal-title":"J Hepatol"},{"key":"2649_CR32","doi-asserted-by":"crossref","unstructured":"Liu G, Huang K, Jie Z, Wu Y, Chen J, Chen Z, Fang X, Shen S. CircFAT1 sponges miR-375 to promote the expression of Yes-associated protein 1 in osteosarcoma cells. Mol Cancer. 2018;17:170.","DOI":"10.1186\/s12943-018-0917-7"},{"key":"2649_CR33","doi-asserted-by":"crossref","unstructured":"Zhang H, Ma X, Wang L, Li X, Feng D, Liu M, Li J, Cheng M, Song N, Yang X, et al. Circular RNA hsa_circ_0007367 promotes the progression of pancreatic ductal adenocarcinoma by sponging miR-6820-3p and upregulating YAP1 expression. Cell Death Dis. 2022;13:736.","DOI":"10.1038\/s41419-022-05188-8"},{"key":"2649_CR34","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41419-020-02784-4","volume":"11","author":"D Wang","year":"2020","unstructured":"Wang D, Luo Y, Wang G, Yang Q. CircATRNL1 promotes epithelial-mesenchymal transition in endometriosis by upregulating Yes-associated protein 1 in vitro. Cell Death Dis. 2020;11:594.","journal-title":"Cell Death Dis"},{"key":"2649_CR35","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.ymthe.2022.01.045","volume":"30","author":"P Xu","year":"2022","unstructured":"Xu P, Zhang J, Wang M, Liu B, Li R, Li H, et al. HnRNPL-activated circANKRD42 back-splicing and circANKRD42-mediated crosstalk of mechanical stiffness and biochemical signal in lung fibrosis. Mol Ther. 2022;30:2370\u201387.","journal-title":"Mol Ther"},{"key":"2649_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215589","volume":"532","author":"Y An","year":"2022","unstructured":"An Y, Xu B, Yan G, Wang N, Yang Z, Sun M. YAP derived circ-LECRC functions as a \u201cbrake signal\u201d to suppress hyperactivation of oncogenic YAP signalling in colorectal cancer. Cancer Lett. 2022;532:215589.","journal-title":"Cancer Lett"},{"key":"2649_CR37","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.2147\/IJN.S407116","volume":"18","author":"F Chao","year":"2023","unstructured":"Chao F, Zhang Y, Lv L, Wei Y, Dou X, Chang N, et al. Extracellular vesicles derived circSH3PXD2A inhibits chemoresistance of small cell lung cancer by miR-375-3p\/YAP1. Int J Nanomedicine. 2023;18:2989\u20133006.","journal-title":"Int J Nanomedicine"},{"key":"2649_CR38","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1002\/jcb.26343","volume":"119","author":"J Xu","year":"2018","unstructured":"Xu J, Ma B, Chen G, Wei D, Li L, Hu W. Microrna-622 suppresses the proliferation of glioma cells by targeting YAP1. J Cell Biochem. 2018;119:2492\u2013500.","journal-title":"J Cell Biochem"},{"key":"2649_CR39","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/ecco-jcc\/jjy046","volume":"12","author":"M Yu","year":"2018","unstructured":"Yu M, Luo Y, Cong Z, Mu Y, Qiu Y, Zhong M. Microrna-590-5p inhibits intestinal inflammation by targeting YAP. J Crohns Colitis. 2018;12:993\u20131004.","journal-title":"J Crohns Colitis"},{"key":"2649_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.139919","volume":"745","author":"W Zha","year":"2020","unstructured":"Zha W, Guan S, Liu N, Li Y, Tian Y, Chen Y, et al. Let-7a inhibits Bcl-xl and YAP1 expression to induce apoptosis of trophoblast cells in early-onset severe preeclampsia. Sci Total Environ. 2020;745:139919.","journal-title":"Sci Total Environ"},{"key":"2649_CR41","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s12272-024-01514-0","volume":"47","author":"YL Lo","year":"2024","unstructured":"Lo YL, Hong CJ, Wang CS, Yang CP. Modulating versatile pathways using a cleavable PEG shell and EGFR-targeted nanoparticles to deliver CRISPR-Cas9 and docetaxel for triple-negative breast cancer inhibition. Arch Pharm Res. 2024;47:829\u201353.","journal-title":"Arch Pharm Res"},{"key":"2649_CR42","doi-asserted-by":"crossref","unstructured":"Chu WK, Hung LM, Hou CW, Chen JK. PKC regulates YAP expression through alternative splicing of YAP 3\u2032UTR pre-mRNA by hnRNP F. Int J Mol Sci. 2021;22:694.","DOI":"10.3390\/ijms22020694"},{"key":"2649_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117543","volume":"243","author":"Y Zhao","year":"2026","unstructured":"Zhao Y, Xu S, Li X, Wu X, Wang L, Wang B, et al. Circ_0057582 inhibits breast cancer progression via hnRNPF\/YAP\/SOX9 axis and M2 polarization in TAMs by autophagic degradation of ISG15. Biochem Pharmacol. 2026;243:117543.","journal-title":"Biochem Pharmacol"},{"key":"2649_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6674283","volume":"2021","author":"J Luo","year":"2021","unstructured":"Luo J, Zou H, Deng L, Sun X, Yuan P, Li P. Lin28 inhibits the differentiation from mouse embryonic stem cells to glial lineage cells through upregulation of Yap1. Stem Cells Int. 2021;2021:6674283.","journal-title":"Stem Cells Int"},{"key":"2649_CR45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10456-020-09744-8","volume":"24","author":"K Qiao","year":"2021","unstructured":"Qiao K, Liu Y, Xu Z, Zhang H, Zhang H, Zhang C, et al. RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway. Angiogenesis. 2021;24:83\u201396.","journal-title":"Angiogenesis"},{"key":"2649_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03225-2","volume":"43","author":"X Bai","year":"2024","unstructured":"Bai X, Liu J, Zhou S, Wu L, Feng X, Zhang P. METTL14 suppresses the expression of YAP1 and the stemness of triple-negative breast cancer. J Exp Clin Cancer Res. 2024;43:307.","journal-title":"J Exp Clin Cancer Res"},{"key":"2649_CR47","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301306R","volume":"37","author":"D Shao","year":"2023","unstructured":"Shao D, Liu C, Wang Y, Lin J, Cheng X, Han P, et al. DNMT1 determines osteosarcoma cell resistance to apoptosis by associatively modulating DNA and mRNA cytosine-5 methylation. FASEB J. 2023;37:e23284.","journal-title":"FASEB J"},{"key":"2649_CR48","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.gene.2012.08.025","volume":"509","author":"CJ Gaffney","year":"2012","unstructured":"Gaffney CJ, Oka T, Mazack V, Hilman D, Gat U, Muramatsu T, et al. Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene. Gene. 2012;509:215\u201322.","journal-title":"Gene"},{"key":"2649_CR49","doi-asserted-by":"crossref","unstructured":"Gao C, Quan MY, Chen QJ, Yang R, Wu Y, Liu JY, Lin ZY, Li X, Cai JT, Jiang TF, et al. Yap1-2 isoform is the primary mediator in TGF-\u03b21 induced EMT in pancreatic cancer. Front Oncol. 2021;11:649290.","DOI":"10.3389\/fonc.2021.649290"},{"key":"2649_CR50","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/jcmm.17150","volume":"26","author":"Q Guo","year":"2022","unstructured":"Guo Q, Quan MY, Xu L, Cai Y, Cai JT, Li X, et al. Enhanced nuclear localization of YAP1-2 contributes to EGF-induced EMT in NSCLC. J Cell Mol Med. 2022;26:1013\u201323.","journal-title":"J Cell Mol Med"},{"key":"2649_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/CAD.0000000000001668","volume":"36","author":"H Chen","year":"2025","unstructured":"Chen H, Xue DK, Wang YX, Jiang TF. aYAP1-2 contributes to bFGF-induced proliferation in gastric cancer. Anticancer Drugs. 2025;36:97\u2013103.","journal-title":"Anticancer Drugs"},{"key":"2649_CR52","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1038\/onc.2012.520","volume":"32","author":"M Sudol","year":"2013","unstructured":"Sudol M. YAP1 oncogene and its eight isoforms. Oncogene. 2013;32:3922.","journal-title":"Oncogene"},{"key":"2649_CR53","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.tibs.2010.05.010","volume":"35","author":"M Sudol","year":"2010","unstructured":"Sudol M, Harvey KF. Modularity in the Hippo signaling pathway. Trends Biochem Sci. 2010;35:627\u201333.","journal-title":"Trends Biochem Sci"},{"key":"2649_CR54","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/onc.2011.216","volume":"31","author":"T Oka","year":"2012","unstructured":"Oka T, Schmitt AP, Sudol M. Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP. Oncogene. 2012;31:128\u201334.","journal-title":"Oncogene"},{"key":"2649_CR55","first-page":"24","volume":"6","author":"ML Finch-Edmondson","year":"2016","unstructured":"Finch-Edmondson ML, Strauss RP, Clayton JS, Yeoh GC, Callus BA. Splice variant insertions in the C-terminus impairs YAP\u2019s transactivation domain. Biochem Biophys Rep. 2016;6:24\u201331.","journal-title":"Biochem Biophys Rep"},{"key":"2649_CR56","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/neuonc\/noac156","volume":"24","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang K, Fu J, Zhang Y, Mao Y, Wang X, et al. FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1. Neuro Oncol. 2022;24:2107\u201320.","journal-title":"Neuro Oncol"},{"key":"2649_CR57","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1016\/j.ymthe.2021.05.012","volume":"29","author":"W Ni","year":"2021","unstructured":"Ni W, Mo H, Liu Y, Xu Y, Qin C, Zhou Y, et al. Targeting cholesterol biosynthesis promotes anti-tumor immunity by inhibiting long noncoding RNA SNHG29-mediated YAP activation. Mol Ther. 2021;29:2995\u20133010.","journal-title":"Mol Ther"},{"key":"2649_CR58","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s12276-024-01210-5","volume":"56","author":"S Park","year":"2024","unstructured":"Park S, Ryu WJ, Kim TY, Hwang Y, Han HJ, Lee JD, et al. Overcoming BRAF and CDK4\/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation. Exp Mol Med. 2024;56:987\u20131000.","journal-title":"Exp Mol Med"},{"key":"2649_CR59","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s11427-023-2737-2","volume":"68","author":"D Wang","year":"2025","unstructured":"Wang D, Zuo S, Ge J, Qu H, Wu J, Yi N, et al. circTP63-N suppresses the proliferation and metastasis of nasopharyngeal carcinoma via engaging with HSP90AB1 to modulate the YAP1\/Hippo signaling pathway. Sci China Life Sci. 2025;68:689\u2013705.","journal-title":"Sci China Life Sci"},{"key":"2649_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101136","volume":"77","author":"Y Gu","year":"2024","unstructured":"Gu Y, Xu T, Fang Y, Shao J, Hu T, Wu X, et al. CBX4 counteracts cellular senescence to desensitize gastric cancer cells to chemotherapy by inducing YAP1 SUMOylation. Drug Resist Updat. 2024;77:101136.","journal-title":"Drug Resist Updat"},{"key":"2649_CR61","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/cas.15285","volume":"113","author":"CK Sinclear","year":"2022","unstructured":"Sinclear CK, Maruyama J, Nagashima S, Arimoto-Matsuzaki K, Kuleape JA, Iwasa H, et al. Protein kinase C\u03b1 activation switches YAP1 from TEAD-mediated signaling to p73-mediated signaling. Cancer Sci. 2022;113:1305\u201320.","journal-title":"Cancer Sci"},{"key":"2649_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53601-x","volume":"15","author":"Y Lei","year":"2024","unstructured":"Lei Y, Liu Q, Chen B, Wu F, Li Y, Dong X, et al. Protein O-GlcNAcylation coupled to Hippo signaling drives vascular dysfunction in diabetic retinopathy. Nat Commun. 2024;15:9334.","journal-title":"Nat Commun"},{"key":"2649_CR63","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.molcel.2017.10.010","volume":"68","author":"C Peng","year":"2017","unstructured":"Peng C, Zhu Y, Zhang W, Liao Q, Chen Y, Zhao X, et al. Regulation of the Hippo-YAP pathway by glucose sensor O-GlcNAcylation. Mol Cell. 2017;68:591-604.e595.","journal-title":"Mol Cell"},{"key":"2649_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15280","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang X, Qiao Y, Wu Q, Chen Y, Zou S, Liu X, et al. The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis. Nat Commun. 2017;8:15280.","journal-title":"Nat Commun"},{"key":"2649_CR65","doi-asserted-by":"crossref","unstructured":"Zhang S, Guo M, Jiang X, Tang L, Wu T, Bi G, Yang X, Fan S, Bi H. PXR triggers YAP-TEAD binding and Sirt2-driven YAP deacetylation and polyubiquitination to promote liver enlargement and regeneration in mice. Pharmacol Res. 2023;188: 106666.","DOI":"10.1016\/j.phrs.2023.106666"},{"key":"2649_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107764","volume":"300","author":"X Chen","year":"2024","unstructured":"Chen X, Li D, Su Q, Ling X, Yang Y, Liu Y, et al. SENP3 mediates the deSUMOylation and degradation of YAP1 to regulate the progression of triple-negative breast cancer. J Biol Chem. 2024;300:107764.","journal-title":"J Biol Chem"},{"key":"2649_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407494","volume":"12","author":"X Cui","year":"2025","unstructured":"Cui X, Zhu Y, Zeng L, Zhang M, Uddin A, Gillespie TW, et al. Pharmacological dissection identifies retatrutide overcomes the therapeutic barrier of obese TNBC treatments through suppressing the interplay between glycosylation and ubiquitylation of YAP. Adv Sci Weinh. 2025;12:e2407494.","journal-title":"Adv Sci Weinh"},{"key":"2649_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01703-9","volume":"22","author":"Y Mo","year":"2023","unstructured":"Mo Y, Leung LL, Mak CSL, Wang X, Chan WS, Hui LMN, et al. Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis. Mol Cancer. 2023;22:4.","journal-title":"Mol Cancer"},{"key":"2649_CR69","doi-asserted-by":"crossref","unstructured":"Mia MM, Ghani S, Cibi DM, Bogireddi H, Nilanthi U, Selvan A, Wong WSF, Singh MK. YAP\/TAZ are crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis after bleomycin-induced injury. Eur Respir J. 2025;65:2301544.","DOI":"10.1183\/13993003.01544-2023"},{"key":"2649_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq5931","volume":"14","author":"N Yin","year":"2022","unstructured":"Yin N, Liu Y, Weems C, Shreeder B, Lou Y, Knutson KL, et al. Protein kinase C\u03b9 mediates immunosuppression in lung adenocarcinoma. Sci Transl Med. 2022;14:eabq5931.","journal-title":"Sci Transl Med"},{"key":"2649_CR71","doi-asserted-by":"publisher","first-page":"7959","DOI":"10.1093\/nar\/gkac624","volume":"50","author":"F Biagioni","year":"2022","unstructured":"Biagioni F, Croci O, Sberna S, Donato E, Sab\u00f2 A, Bisso A, et al. Decoding YAP dependent transcription in the liver. Nucleic Acids Res. 2022;50:7959\u201371.","journal-title":"Nucleic Acids Res"},{"key":"2649_CR72","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/HEP.0000000000000773","volume":"81","author":"S Zhang","year":"2025","unstructured":"Zhang S, Sun Z, Chen Z, Bi Y, Wei S, Mao Z, et al. Endothelial YAP\/TEAD1-CXCL17 signaling recruits myeloid-derived suppressor cells against liver ischemia-reperfusion injury. Hepatology. 2025;81:888\u2013902.","journal-title":"Hepatology"},{"key":"2649_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57697-7","volume":"16","author":"X Lv","year":"2025","unstructured":"Lv X, Liu J, Ruan J, Chen P, He C, Zhao X, et al. Targeting the disrupted Hippo signaling to prevent neoplastic renal epithelial cell immune evasion. Nat Commun. 2025;16:2858.","journal-title":"Nat Commun"},{"key":"2649_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04458-z","volume":"21","author":"YL Yang","year":"2023","unstructured":"Yang YL, Zhou C, Chen Q, Shen SZ, Li JD, Wang XL, et al. YAP1\/Piezo1 involve in the dynamic changes of lymphatic vessels in UVR-induced photoaging progress to squamous cell carcinoma. J Transl Med. 2023;21:820.","journal-title":"J Transl Med"},{"key":"2649_CR75","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1053\/j.gastro.2025.01.240","volume":"168","author":"X Chen","year":"2025","unstructured":"Chen X, Fu H, Zhu S, Xiang Z, Fu H, Sun Z, et al. The moonlighting function of glutaminase 2 promotes immune evasion of pancreatic ductal adenocarcinoma by tubulin tyrosine ligase-like 1-mediated Yes1 associated transcriptional regulator glutamylation. Gastroenterology. 2025;168:1137\u201352.","journal-title":"Gastroenterology"},{"key":"2649_CR76","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/cac2.12609","volume":"44","author":"J Jiang","year":"2024","unstructured":"Jiang J, Ye P, Sun N, Zhu W, Yang M, Yu M, et al. Yap methylation-induced FGL1 expression suppresses anti-tumor immunity and promotes tumor progression in KRAS-driven lung adenocarcinoma. Cancer Commun. 2024;44:1350\u201373.","journal-title":"Cancer Commun"},{"key":"2649_CR77","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41418-025-01446-2","volume":"32","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Ding R, Yu W, Liu Y, Zhou Z, Liu CY. YAP\/TEAD4\/SP1-induced VISTA expression as a tumor cell-intrinsic mechanism of immunosuppression in colorectal cancer. Cell Death Differ. 2025;32:911\u201325.","journal-title":"Cell Death Differ"},{"key":"2649_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202501956","author":"J Guo","year":"2025","unstructured":"Guo J, Wang Y, Liu Q, Luo Z, Tian X, Wang Y, et al. Nephronectin (NPNT) is a Crucial Determinant of Idiopathic Pulmonary Fibrosis: Modulating Cellular Senescence via the ITGA3\/YAP1 Signaling Axis. Advanced Science. 2025. https:\/\/doi.org\/10.1002\/advs.202501956.","journal-title":"Advanced Science"},{"key":"2649_CR79","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41418-024-01333-2","volume":"31","author":"JJ Park","year":"2024","unstructured":"Park JJ, Lee SJ, Baek M, Lee OJ, Nam S, Kim J, et al. FRMD6 determines the cell fate towards senescence: involvement of the Hippo-YAP-CCN3 axis. Cell Death Differ. 2024;31:1398\u2013409.","journal-title":"Cell Death Differ"},{"key":"2649_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56929-0","volume":"16","author":"J Joung","year":"2025","unstructured":"Joung J, Heo Y, Kim Y, Kim J, Choi H, Jeon T, et al. Cell enlargement modulated by GATA4 and YAP instructs the senescence-associated secretory phenotype. Nat Commun. 2025;16:1696.","journal-title":"Nat Commun"},{"key":"2649_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300424","volume":"10","author":"X Yang","year":"2023","unstructured":"Yang X, Zong C, Feng C, Zhang C, Smirnov A, Sun G, et al. Hippo pathway activation in aged mesenchymal stem cells contributes to the dysregulation of hepatic inflammation in aged mice. Adv Sci. 2023;10:e2300424.","journal-title":"Adv Sci"},{"key":"2649_CR82","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/procel\/pwae017","volume":"15","author":"Q Hu","year":"2024","unstructured":"Hu Q, Zhang B, Jing Y, Ma S, Hu L, Li J, et al. Single-nucleus transcriptomics uncovers a geroprotective role of YAP in primate gingival aging. Protein Cell. 2024;15:612\u201332.","journal-title":"Protein Cell"},{"key":"2649_CR83","doi-asserted-by":"crossref","unstructured":"Kashihara T, Mukai R, Oka SI, Zhai P, Nakada Y, Yang Z, Mizushima W, Nakahara T, Warren JS, Abdellatif M, Sadoshima J. YAP mediates compensatory cardiac hypertrophy through aerobic glycolysis in response to pressure overload. J Clin Invest. 2022;132:e150595.","DOI":"10.1172\/JCI150595"},{"key":"2649_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304617","volume":"11","author":"J Yang","year":"2024","unstructured":"Yang J, Li S, Li Z, Yao L, Liu M, Tong KL, et al. Targeting YAP1-regulated glycolysis in fibroblast-like synoviocytes impairs macrophage infiltration to ameliorate diabetic osteoarthritis progression. Adv Sci. 2024;11:e2304617.","journal-title":"Adv Sci"},{"key":"2649_CR85","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10456-020-09760-8","volume":"24","author":"Y Feng","year":"2021","unstructured":"Feng Y, Zou R, Zhang X, Shen M, Chen X, Wang J, et al. YAP promotes ocular neovascularization by modifying PFKFB3-driven endothelial glycolysis. Angiogenesis. 2021;24:489\u2013504.","journal-title":"Angiogenesis"},{"key":"2649_CR86","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.canlet.2021.07.025","volume":"518","author":"S Lin","year":"2021","unstructured":"Lin S, Li Y, Wang D, Huang C, Marino D, Bollt O, et al. Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression. Cancer Lett. 2021;518:230\u201342.","journal-title":"Cancer Lett"},{"key":"2649_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202500610","volume":"12","author":"C Ma","year":"2025","unstructured":"Ma C, Hua Y, Yang S, Zhao Y, Zhang W, Miao Y, et al. Wogonin attenuates atherosclerosis via KLF11-mediated suppression of PPAR\u03b1-YAP1-driven glycolysis and enhancement of ABCA1\/G1-mediated cholesterol efflux. Adv Sci Weinh. 2025;12:e2500610.","journal-title":"Adv Sci Weinh"},{"key":"2649_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52888-0","volume":"15","author":"C Zhu","year":"2024","unstructured":"Zhu C, Chen X, Liu TQ, Cheng L, Cheng W, Cheng P, et al. Hexosaminidase B-driven cancer cell-macrophage co-dependency promotes glycolysis addiction and tumorigenesis in glioblastoma. Nat Commun. 2024;15:8506.","journal-title":"Nat Commun"},{"key":"2649_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51117-y","volume":"15","author":"S Kang","year":"2024","unstructured":"Kang S, Antoniewicz MR, Hay N. Metabolic and transcriptomic reprogramming during contact inhibition-induced quiescence is mediated by YAP-dependent and YAP-independent mechanisms. Nat Commun. 2024;15:6777.","journal-title":"Nat Commun"},{"key":"2649_CR90","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","volume":"154","author":"K Du","year":"2018","unstructured":"Du K, Hyun J, Premont RT, Choi SS, Michelotti GA, Swiderska-Syn M, et al. Hedgehog-YAP signaling pathway regulates glutaminolysis to control activation of hepatic stellate cells. Gastroenterology. 2018;154:1465-1479.e1413.","journal-title":"Gastroenterology"},{"key":"2649_CR91","doi-asserted-by":"crossref","unstructured":"Edwards DN, Ngwa VM, Wang S, Shiuan E, Brantley-Sieders DM, Kim LC, Reynolds AB, Chen J. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ. Sci Signal. 2017;10:eaan4667.","DOI":"10.1126\/scisignal.aan4667"},{"key":"2649_CR92","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1002\/1878-0261.12999","volume":"15","author":"P Kandasamy","year":"2021","unstructured":"Kandasamy P, Zlobec I, Nydegger DT, Pujol-Gim\u00e9nez J, Bhardwaj R, Shirasawa S, et al. Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1. Mol Oncol. 2021;15:2782\u2013800.","journal-title":"Mol Oncol"},{"key":"2649_CR93","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019091","volume":"10","author":"AP Acharya","year":"2021","unstructured":"Acharya AP, Tang Y, Bertero T, Tai YY, Harvey LD, Woodcock CC, et al. Simultaneous pharmacologic inhibition of Yes-Associated Protein 1 and glutaminase 1 via inhaled poly(lactic-co-glycolic) acid-encapsulated microparticles improves pulmonary hypertension. J Am Heart Assoc. 2021;10:e019091.","journal-title":"J Am Heart Assoc"},{"key":"2649_CR94","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1158\/0008-5472.CAN-23-3933","volume":"84","author":"M Park","year":"2024","unstructured":"Park M, Jin J, An DY, Kim DH, Lee J, Yun JW, et al. Targeting YAP activity and glutamine metabolism cooperatively suppresses tumor progression by preventing extracellular matrix accumulation. Cancer Res. 2024;84:3388\u2013401.","journal-title":"Cancer Res"},{"key":"2649_CR95","doi-asserted-by":"crossref","unstructured":"Yang CS, Stampouloglou E, Kingston NM, Zhang L, Monti S, Varelas X. Glutamine-utilizing transaminases are a metabolic vulnerability of TAZ\/YAP-activated cancer cells. EMBO Rep. 2018;19:e43577.","DOI":"10.15252\/embr.201643577"},{"key":"2649_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07806-7","volume":"16","author":"X Luo","year":"2025","unstructured":"Luo X, Zhu Z, Zheng T, Li D, Wei Y, Yang H, et al. Astrocytic YAP prevents the glutamate neurotoxicity by upregulation of EAAT2 expression and promotes the gain of stemness in astrocytes in ischemic stroke mice. Cell Death Dis. 2025;16:577.","journal-title":"Cell Death Dis"},{"key":"2649_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05919-5","volume":"14","author":"YC Yan","year":"2023","unstructured":"Yan YC, Meng GX, Yang CC, Yang YF, Tan SY, Yan LJ, et al. Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity. Cell Death Dis. 2023;14:404.","journal-title":"Cell Death Dis"},{"key":"2649_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409883","volume":"12","author":"J Wang","year":"2025","unstructured":"Wang J, Shen D, Jiang J, Hu L, Fang K, Xie C, et al. Dietary palmitic acid drives a palmitoyltransferase ZDHHC15-YAP feedback loop promoting tumor metastasis. Adv Sci (Weinh). 2025;12:e2409883.","journal-title":"Adv Sci (Weinh)"},{"key":"2649_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23240-7","volume":"12","author":"KI Watt","year":"2021","unstructured":"Watt KI, Henstridge DC, Ziemann M, Sim CB, Montgomery MK, Samocha-Bonet D, et al. Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease. Nat Commun. 2021;12:2887.","journal-title":"Nat Commun"},{"key":"2649_CR100","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/s12276-024-01280-5","volume":"56","author":"D Xu","year":"2024","unstructured":"Xu D, Qu X, Yang T, Sheng M, Bian X, Zhan Y, et al. The Foxo1-YAP-Notch1 axis reprograms STING-mediated innate immunity in NASH progression. Exp Mol Med. 2024;56:1843\u201355.","journal-title":"Exp Mol Med"},{"key":"2649_CR101","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.7150\/thno.22048","volume":"8","author":"D-W Wu","year":"2018","unstructured":"Wu D-W, Wang Y-C, Wang L, Chen CY, Lee H. A low microrna-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via mir-630\/YAP1\/ERK feedback loop. Theranostics. 2018;8:1256\u201369.","journal-title":"Theranostics"},{"key":"2649_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02776-y","volume":"22","author":"J Qi","year":"2024","unstructured":"Qi J, Zhang L, Ren Z, Yuan Y, Yu J, Zhang Y, et al. Stepwise-targeting and hypoxia-responsive liposome AMVY@NPs carrying siYAP and verteporfin for glioblastoma therapy. J Nanobiotechnology. 2024;22:495.","journal-title":"J Nanobiotechnology"},{"key":"2649_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116460","volume":"229","author":"HC Tsai","year":"2024","unstructured":"Tsai HC, Tsai MH, Hua CH, Huang CW, Lu CC, Chen KJ, et al. Circ_0002722-induced regulation of YAP promotes platinum resistance in oral squamous cell carcinoma: implications for verteporfin therapy. Biochem Pharmacol. 2024;229:116460.","journal-title":"Biochem Pharmacol"},{"key":"2649_CR104","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.jhep.2014.06.033","volume":"61","author":"A Perra","year":"2014","unstructured":"Perra A, Kowalik MA, Ghiso E, Ledda-Columbano GM, Di Tommaso L, Angioni MM, et al. YAP activation is an early event and a potential therapeutic target in liver cancer development. J Hepatol. 2014;61:1088\u201396.","journal-title":"J Hepatol"},{"key":"2649_CR105","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1038\/s41418-020-0492-5","volume":"27","author":"B Cai","year":"2020","unstructured":"Cai B, Ma W, Wang X, Sukhareva N, Hua B, Zhang L, et al. Targeting LncDACH1 promotes cardiac repair and regeneration after myocardium infarction. Cell Death Differ. 2020;27:2158\u201375.","journal-title":"Cell Death Differ"},{"key":"2649_CR106","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.jconrel.2025.02.051","volume":"380","author":"F Chen","year":"2025","unstructured":"Chen F, Kang NW, Wungcharoen T, Jiang L, Basco CA, Garcia-Sanchez J, et al. Repurposing verteporfin and hyaluronic acid gel for ocular surface treatment to prevent corneal scarring. J Control Release. 2025;380:1141\u201351.","journal-title":"J Control Release"},{"key":"2649_CR107","first-page":"6490","volume":"12","author":"N Chen","year":"2020","unstructured":"Chen N, Han X, Bai X, Yin B, Wang Y. LASP1 induces colorectal cancer proliferation and invasiveness through Hippo signaling and Nanog mediated EMT. Am J Transl Res. 2020;12:6490\u2013500.","journal-title":"Am J Transl Res"},{"key":"2649_CR108","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.7150\/ijbs.79965","volume":"19","author":"Y Ning","year":"2023","unstructured":"Ning Y, Zheng H, Yang Y, Zang H, Wang W, Zhan Y, et al. YAP1 synergize with YY1 transcriptional co-repress DUSP1 to induce osimertinib resistant by activating the EGFR\/MAPK pathway and abrogating autophagy in non-small cell lung cancer. Int J Biol Sci. 2023;19:2458\u201374.","journal-title":"Int J Biol Sci"},{"key":"2649_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-11652-0","volume":"15","author":"SR Woo","year":"2025","unstructured":"Woo SR, Noh JK, Lee MK, Kong M, Min S, Sung JY, et al. Blocking YAP1-Liprin-\u03b22 interaction impedes metastasis and promotes tumor suppression in head and neck squamous carcinoma. Sci Rep. 2025;15:26968.","journal-title":"Sci Rep"},{"key":"2649_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-30686-y","volume":"16","author":"NP Ozates","year":"2026","unstructured":"Ozates NP, Bagca BG, Asik A, Gunduz C, Akin H, Avci CB. The impact of inhibiting the Hippo signaling pathway effector molecule YAP1 on in vitro glioblastoma and glioblastoma stem cells. Sci Rep. 2026;16:3679.","journal-title":"Sci Rep"},{"key":"2649_CR111","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1136\/ard-2023-223859","volume":"82","author":"P Chitturi","year":"2023","unstructured":"Chitturi P, Xu S, Ahmed Abdi B, Nguyen J, Carter DE, Sinha S, et al. Tripterygium wilfordii derivative celastrol, a YAP inhibitor, has antifibrotic effects in systemic sclerosis. Ann Rheum Dis. 2023;82:1191\u2013204.","journal-title":"Ann Rheum Dis"},{"key":"2649_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2024.105910","volume":"160","author":"A Naik","year":"2024","unstructured":"Naik A, Chitturi P, Nguyen J, Leask A. The yes-associated protein-1 (YAP1) inhibitor celastrol suppresses the ability of transforming growth factor \u03b2 to activate human gingival fibroblasts. Arch Oral Biol. 2024;160:105910.","journal-title":"Arch Oral Biol"},{"key":"2649_CR113","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s11684-022-0978-2","volume":"17","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Shi X, Ji J, Guo Y, Peng Q, Hao L, et al. Dihydroartemisinin increased the abundance of Akkermansia muciniphila by YAP1 depression that sensitizes hepatocellular carcinoma to anti-PD-1 immunotherapy. Front Med. 2023;17:729\u201346.","journal-title":"Front Med"},{"key":"2649_CR114","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11418-022-01641-2","volume":"77","author":"Q Peng","year":"2023","unstructured":"Peng Q, Hao L, Guo Y, Zhang Z, Ji J, Xue Y, et al. Dihydroartemisinin inhibited the Warburg effect through YAP1\/SLC2A1 pathway in hepatocellular carcinoma. J Nat Med. 2023;77:28\u201340.","journal-title":"J Nat Med"},{"key":"2649_CR115","doi-asserted-by":"publisher","first-page":"107666","DOI":"10.18632\/oncotarget.22587","volume":"8","author":"S Nambara","year":"2017","unstructured":"Nambara S, Masuda T, Nishio M, Kuramitsu S, Tobo T, Ogawa Y, et al. Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer. Oncotarget. 2017;8:107666\u201377.","journal-title":"Oncotarget"},{"key":"2649_CR116","doi-asserted-by":"crossref","unstructured":"Kim SL, Choi HS, Kim JH, Lee DS. The antiasthma medication ciclesonide suppresses breast cancer stem cells through inhibition of the glucocorticoid receptor signaling-dependent YAP pathway. Molecules. 2020;25:6028.","DOI":"10.3390\/molecules25246028"},{"key":"2649_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-01879-w","volume":"40","author":"W Su","year":"2021","unstructured":"Su W, Zhu S, Chen K, Yang H, Tian M, Fu Q, et al. Overexpressed WDR3 induces the activation of Hippo pathway by interacting with GATA4 in pancreatic cancer. J Exp Clin Cancer Res. 2021;40:88.","journal-title":"J Exp Clin Cancer Res"},{"key":"2649_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156287","volume":"136","author":"ZQ Wang","year":"2025","unstructured":"Wang ZQ, Wu ZX, Chen JW, Li HF, Wu HD, Bao JX, et al. Cyclovirobuxine D inhibits triple-negative breast cancer via YAP\/TAZ suppression and activation of the FOXO3a\/PINK1-Parkin pathway-induced mitophagy. Phytomedicine. 2025;136:156287.","journal-title":"Phytomedicine"},{"key":"2649_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217695","volume":"621","author":"S Song","year":"2025","unstructured":"Song S, Fan Y, Zou G, Huo L, Kumar J, Li Y, et al. KAP1 promotes gastric adenocarcinoma progression by activating Hippo\/YAP1 signaling via binding to HNRNPAB. Cancer Lett. 2025;621:217695.","journal-title":"Cancer Lett"},{"key":"2649_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123914","volume":"379","author":"M Arioka","year":"2025","unstructured":"Arioka M, Matsunaga H, Ishikane S, Ito K, Hashimoto K, Wang Y, et al. Celecoxib inhibits skin fibrosis via suppressing adipocyte progenitor-myofibroblast transdifferentiation by attenuating the YAP\/TAZ signaling pathway. Life Sci. 2025;379:123914.","journal-title":"Life Sci"},{"key":"2649_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120292","volume":"353","author":"HS Seo","year":"2025","unstructured":"Seo HS, Kim HG, Joo H, Kwon J, Cho JH. Injinoryeong-San attenuates metabolic dysfunction-associated steatohepatitis via regulation of YAP\/TAZ-signaling pathway. J Ethnopharmacol. 2025;353:120292.","journal-title":"J Ethnopharmacol"},{"key":"2649_CR122","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/cas.70075","volume":"116","author":"K Hosoya","year":"2025","unstructured":"Hosoya K, Ozasa H, Yoshida H, Ajimizu H, Tsuji T, Yamazoe M, et al. Novel TEAD1 Inhibitor VT103 Enhances Dabrafenib Efficacy in BRAF V600E Mutated Lung Adenocarcinoma via Survivin Downregulation. Cancer Sci. 2025;116:1883\u201396.","journal-title":"Cancer Sci"},{"key":"2649_CR123","doi-asserted-by":"publisher","first-page":"7956","DOI":"10.7150\/thno.113303","volume":"15","author":"P Weng","year":"2025","unstructured":"Weng P, Wen Y, Yuan Z, Ma L, Yang L, Li C, et al. O-GlcNAcylation-dependent liquid-liquid phase separation regulates the nuclear translocation of YAP to exacerbate vascular neointimal hyperplasia. Theranostics. 2025;15:7956\u201372.","journal-title":"Theranostics"},{"key":"2649_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2025.171441","volume":"193","author":"L Li","year":"2025","unstructured":"Li L, Wang H, Zhao C. Salusin-\u03b1 preserves glomerular endothelial barrier function in hypertension via YAP\/ZO-1 signaling pathway. Peptides. 2025;193:171441.","journal-title":"Peptides"},{"key":"2649_CR125","doi-asserted-by":"publisher","first-page":"12713","DOI":"10.1007\/s00210-025-04120-z","volume":"398","author":"W Liu","year":"2025","unstructured":"Liu W, Liu R, Yang Y, Cheng L, Feng X, Li Q. The targeting of YAP by kaempferol regulates bone homeostasis and improves osteoporosis in rats. Naunyn Schmiedebergs Arch Pharmacol. 2025;398:12713\u201325.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2649_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64426-7","volume":"16","author":"R Zhou","year":"2025","unstructured":"Zhou R, Wang H, Zhang GM, Liu Y, Liu XL, Li Z, et al. Targeted degradation of endogenous YAP by nanobody bioPROTAC inhibits tumor progression. Nat Commun. 2025;16:9374.","journal-title":"Nat Commun"},{"key":"2649_CR127","doi-asserted-by":"crossref","unstructured":"Zhu W, Chen Y, Wu X, Fu X, He Y, Mo Y, Zhu Q, Tang M, Zhai Z. Schisantherin a induces ferroptosis in non\u2011small cell lung cancer through activation of the YAP\/ACSL4\/TfR signaling pathway. Mol Med Rep. 2026;33:24.","DOI":"10.3892\/mmr.2025.13734"},{"key":"2649_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48081-9","volume":"9","author":"DP Provvisiero","year":"2019","unstructured":"Provvisiero DP, Negri M, de Angelis C, Di Gennaro G, Patalano R, Simeoli C, et al. Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375\/oncogenes circuit. Sci Rep. 2019;9:11695.","journal-title":"Sci Rep"},{"key":"2649_CR129","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12976","volume":"54","author":"T Zhang","year":"2021","unstructured":"Zhang T, Guo S, Zhou H, Wu Z, Liu J, Qiu C, et al. Endometrial extracellular matrix rigidity and IFN\u03c4 ensure the establishment of early pregnancy through activation of YAP. Cell Prolif. 2021;54:e12976.","journal-title":"Cell Prolif"},{"key":"2649_CR130","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/s41401-020-0495-2","volume":"42","author":"WY Ma","year":"2021","unstructured":"Ma WY, Song RJ, Xu BB, Xu Y, Wang XX, Sun HY, et al. Melatonin promotes cardiomyocyte proliferation and heart repair in mice with myocardial infarction via miR-143-3p\/Yap\/Ctnnd1 signaling pathway. Acta Pharmacol Sin. 2021;42:921\u201331.","journal-title":"Acta Pharmacol Sin"},{"key":"2649_CR131","doi-asserted-by":"crossref","unstructured":"Nguyen MT, Min KH, Lee W. Palmitic acid-induced miR-429-3p impairs myoblast differentiation by downregulating CFL2. Int J Mol Sci. 2021;22:10972.","DOI":"10.3390\/ijms222010972"},{"key":"2649_CR132","doi-asserted-by":"publisher","first-page":"5304","DOI":"10.1111\/jcmm.15186","volume":"24","author":"Y Jia","year":"2020","unstructured":"Jia Y, Jin H, Gao L, Yang X, Wang F, Ding H, et al. A novel lncRNA PLK4 up-regulated by talazoparib represses hepatocellular carcinoma progression by promoting YAP-mediated cell senescence. J Cell Mol Med. 2020;24:5304\u201316.","journal-title":"J Cell Mol Med"},{"key":"2649_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156879","volume":"143","author":"X Zhou","year":"2025","unstructured":"Zhou X, Zhang C, Shen W, Zhuang R, Liu S, Liu J. Curzerene suppresses epithelial-mesenchymal transition in gastric precancerous lesion cells through targeted regulation of YAP via the long non-coding RNA AFAP1-AS1. Phytomedicine. 2025;143:156879.","journal-title":"Phytomedicine"},{"key":"2649_CR134","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1038\/s41401-021-00754-w","volume":"42","author":"ZN Lu","year":"2021","unstructured":"Lu ZN, Niu WX, Zhang N, Ge MX, Bao YY, Ren Y, et al. Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation. Acta Pharmacol Sin. 2021;42:1808\u201320.","journal-title":"Acta Pharmacol Sin"},{"key":"2649_CR135","doi-asserted-by":"publisher","first-page":"393","DOI":"10.7150\/jca.77322","volume":"14","author":"CH Wang","year":"2023","unstructured":"Wang CH, Baskaran R, Ng SS, Wang TF, Li CC, Ho TJ, et al. Platycodin D confers oxaliplatin resistance in colorectal cancer by activating the LATS2\/YAP1 axis of the hippo signaling pathway. J Cancer. 2023;14:393\u2013402.","journal-title":"J Cancer"},{"key":"2649_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.177002","volume":"983","author":"K Ren","year":"2024","unstructured":"Ren K, Wang X, Ma R, Chen H, Min T, Ma Y, et al. Dapagliflozin suppressed gastric cancer growth via regulating OTUD5 mediated YAP1 deubiquitination. Eur J Pharmacol. 2024;983:177002.","journal-title":"Eur J Pharmacol"},{"key":"2649_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116468","volume":"272","author":"Y Lu","year":"2024","unstructured":"Lu Y, Gao J, Wang P, Chen H, He X, Luo M, et al. Discovery of potent small molecule ubiquitin-specific protease 10 inhibitors with anti-hepatocellular carcinoma activity through regulating YAP expression. Eur J Med Chem. 2024;272:116468.","journal-title":"Eur J Med Chem"},{"key":"2649_CR138","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/jog.15922","volume":"50","author":"F Liu","year":"2024","unstructured":"Liu F, Zhang Y, Xia X, Han J, Cao L. Honokiol induces ferroptosis in ovarian cancer cells through the regulation of YAP by OTUB2. J Obstet Gynaecol Res. 2024;50:864\u201372.","journal-title":"J Obstet Gynaecol Res"},{"key":"2649_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116904","volume":"236","author":"Y Han","year":"2025","unstructured":"Han Y, Kong W, Shang Q, Liu Y, Ni X, Yang L, et al. Discovery of targeting USP10-mediated proline metabolism arrangement to inhibit hepatocellular carcinoma progression. Biochem Pharmacol. 2025;236:116904.","journal-title":"Biochem Pharmacol"},{"key":"2649_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07599-9","volume":"16","author":"C Lu","year":"2025","unstructured":"Lu C, Liu H, Liu T, Sun S, Zheng Y, Ling T, et al. RIPK2 promotes colorectal cancer metastasis by protecting YAP degradation from ITCH-mediated ubiquitination. Cell Death Dis. 2025;16:248.","journal-title":"Cell Death Dis"},{"key":"2649_CR141","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1158\/1535-7163.MCT-24-0594","volume":"24","author":"I Kaushik","year":"2025","unstructured":"Kaushik I, Rajan R, Gaikwad S, Eltokhy MA, Srivastava SK. Moxidectin unravels the role of the Hippo-YAP pathway in maintaining immunity of glioblastoma multiforme. Mol Cancer Ther. 2025;24:1156\u201370.","journal-title":"Mol Cancer Ther"},{"key":"2649_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102420","volume":"6","author":"N Su","year":"2025","unstructured":"Su N, Lian W, Zhang B, Tian Y, Li L, Chen Y, et al. Inhibiting NEDD4 in triple-negative breast cancer cells reprograms tumor immune microenvironment via the \u03b2-TrCP\/YAP\/ECM axis. Cell Rep Med. 2025;6:102420.","journal-title":"Cell Rep Med"},{"key":"2649_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.842214","volume":"10","author":"P Feng","year":"2022","unstructured":"Feng P, Zhang J, Zhang J, Liu X, Pan L, Chen D, et al. Deacetylation of YAP1 promotes the resistance to chemo- and targeted therapy in FLT3-ITD(+) AML cells. Front Cell Dev Biol. 2022;10:842214.","journal-title":"Front Cell Dev Biol"},{"key":"2649_CR144","doi-asserted-by":"crossref","unstructured":"Kim YS, Kim M, Cho DI, Lim SY, Jun JH, Kim MR, Kang BG, Eom GH, Kang G, Yoon S, Ahn Y. PSME4 degrades acetylated YAP1 in the nucleus of mesenchymal stem cells. Pharmaceutics. 2022;14:1659.","DOI":"10.3390\/pharmaceutics14081659"},{"key":"2649_CR145","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/neuonc\/noab244","volume":"24","author":"AM Barrette","year":"2022","unstructured":"Barrette AM, Ronk H, Joshi T, Mussa Z, Mehrotra M, Bouras A, et al. Anti-invasive efficacy and survival benefit of the YAP-TEAD inhibitor verteporfin in preclinical glioblastoma models. Neuro Oncol. 2022;24:694\u2013707.","journal-title":"Neuro Oncol"},{"key":"2649_CR146","first-page":"1207","volume":"10","author":"B Wang","year":"2020","unstructured":"Wang B, Shao W, Shi Y, Liao J, Chen X, Wang C. Verteporfin induced SUMOylation of YAP1 in endometrial cancer. Am J Cancer Res. 2020;10:1207\u201317.","journal-title":"Am J Cancer Res"},{"key":"2649_CR147","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00885-3","volume":"13","author":"X Li","year":"2020","unstructured":"Li X, Song Y. Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy. J Hematol Oncol. 2020;13:50.","journal-title":"J Hematol Oncol"},{"key":"2649_CR148","doi-asserted-by":"crossref","unstructured":"Prakash S. Nano-based drug delivery system for therapeutics: a comprehensive review. Biomed Phys Eng Express. 2023;9.","DOI":"10.1088\/2057-1976\/acedb2"},{"key":"2649_CR149","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1158\/1541-7786.MCR-21-0310","volume":"20","author":"T Alhousami","year":"2022","unstructured":"Alhousami T, Diny M, Ali F, Shin J, Kumar G, Kumar V, et al. Inhibition of LSD1 attenuates oral cancer development and promotes therapeutic efficacy of immune checkpoint blockade and YAP\/TAZ inhibition. Mol Cancer Res. 2022;20:712\u201321.","journal-title":"Mol Cancer Res"},{"key":"2649_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22544-y","volume":"12","author":"G Della Chiara","year":"2021","unstructured":"Della Chiara G, Gervasoni F, Fakiola M, Godano C, D\u2019Oria C, Azzolin L, et al. Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP\/TAZ. Nat Commun. 2021;12:2340.","journal-title":"Nat Commun"},{"key":"2649_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01309-7","volume":"8","author":"T Li","year":"2023","unstructured":"Li T, Yang Y, Qi H, Cui W, Zhang L, Fu X, et al. CRISPR\/Cas9 therapeutics: progress and prospects. Signal Transduct Target Ther. 2023;8:36.","journal-title":"Signal Transduct Target Ther"},{"key":"2649_CR152","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.devcel.2018.09.021","volume":"47","author":"A Lavado","year":"2018","unstructured":"Lavado A, Park JY, Par\u00e9 J, Finkelstein D, Pan H, Xu B, et al. The Hippo pathway prevents YAP\/TAZ-driven hypertranscription and controls neural progenitor number. Dev Cell. 2018;47:576-591.e578.","journal-title":"Dev Cell"},{"key":"2649_CR153","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.tig.2024.08.005","volume":"40","author":"YK Kim","year":"2024","unstructured":"Kim YK, Collignon E, Martin SB, Ramalho-Santos M. Hypertranscription: the invisible hand in stem cell biology. Trends Genet. 2024;40:1032\u201346.","journal-title":"Trends Genet"},{"key":"2649_CR154","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.molcel.2015.09.001","volume":"60","author":"GG Galli","year":"2015","unstructured":"Galli GG, Carrara M, Yuan WC, Valdes-Quezada C, Gurung B, Pepe-Mooney B, et al. YAP drives growth by controlling transcriptional pause release from dynamic enhancers. Mol Cell. 2015;60:328\u201337.","journal-title":"Mol Cell"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02649-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02649-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02649-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:09:47Z","timestamp":1778645387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02649-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":154,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2649"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02649-y","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}